Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Baraclude

Lexapro generics hammer Forest Labs’ Q3 results

Sales down by nearly 40 per cent

- PMLiVE

Indonesia breaks seven HIV, hepatitis drug patents

Merck & Co, GSK, Gilead, Abbott and BMS all effected

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

Teva pulls generic version of antidepressant Wellbutrin XL in US

FDA says copy is not equivalent to branded drug

- PMLiVE

Sanofi acquires Colombian pharma manufacturing firm Genfar

Expands its Latin American generics portfolio

- PMLiVE

MSF unveils website to help pharma patent challengers

Patent Opposition Database contains patents facing opposition

Frances Heller joins BMS senior management

Takes up business development role and will report to Lamberto Andreotti

FDA sets new date for Eliquis review in atrial fibrillation

US regulator had asked for more data from Pfizer and BMS

- PMLiVE

Bayer fails to block Indian Nexavar compulsory licence

Loses ‘stay’ appeal against Natco Pharma in Chennai court

- PMLiVE

Bayer buys Teva animal health unit

Deal valued at $145m

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

Roche loses Indian Tarceva patent battle with Cipla

As Novartis' Glivec patent law challenge begins again

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links